|
Clinical Training in Medical Oncology
Welcome!
Medical Oncology is an exciting speciality exploding with new understanding about Cancer and its treatments.
We are looking for highly motivated, committed and empathic individuals to join us as Advanced Trainee Registrars.
This page contains some further information about training in Medical Oncology at the Prince of Wales (POW), St George
and Wollongong Hospitals.
Training in SESIAHS
On January 1, 2005 the Illawarra Area Health Service and South Eastern Sydney Area Health Service were amalgamated into a single entity, the South Eastern Sydney and Illawarra Area Health Service (SESIAHS). SESIAHS covers approximately 6,331 square kilometres, stretching from Sydney Harbour in the north to Durras in the south. The Area includes highly urbanised areas of eastern Sydney, southern Sydney, Wollongong and Port Kembla, which contrast with the predominantly rural areas of Kiama and Shoalhaven. There are approximately 1.16 million residents living in the area covered by SESIAHS, 17% of the population of NSW. About SESIAHS - Boundaries
Prince of Wales, St George and Wollongong Hospitals are major referral centres within SESIAHS. For many years, Advanced Trainees in Medical Oncology were jointly recruited at Prince of Wales and St George Hospitals, spending a year at each. Wollongong Hospital was included in this process in 2008. Sub-speciality training in Medical Oncology takes 3 years. This includes 2 years of core training in Medical Oncology and an elective year. For more information, check out the Royal Australasian College of Physicians training website.
Training at the different hospitals will allow you to undergo a variety of experiences in general, sub-speciality, rural and outreach oncology practices. You will learn to care for patients under the guidance of experienced clinicians, be given the opportunity to do clinical research, receive expert tutorials and contribute to the teaching of your colleagues and other health professionals, and work as part of a committed team.
Medical Oncologists
Prince of Wales | St George | Wollongong |
| | |
* Head of Department
** RACP Lead Supervisor for Advanced Trainees
Past and Present Trainees
Year |
Prince of Wales |
St George |
Wollongong |
2009 |
Charlotte Lemech/Alan Landau
Kate Webber |
Bavanthi Balakrishnar
Arthur Clements
Rasha Cosman
Katrin Sjoquist |
Alan Landau/Charlotte Lemech |
2008 |
Mamta Bagia
Katrin Sjoquist |
Morteza Aghemesh
Carole Harris
Kate Webber |
|
2007 |
Chee Lee
Carole Harris |
Mamta Bagia
Patricia Bastick
Melvin Chin
Tracey Dunlop
Alison Hadley |
Morteza Aghemesh
Lorraine Chantrill |
2006 |
Patricia Bastick
Alison Hadley |
Melvin Chin
Tracey Dunlop
Chee Lee |
Lorraine Chantrill |
2005 |
Melvin Chin
Kelly Mok |
Patricia Bastick
Peter Grimison
Jason Kaplan |
|
2004 |
Peter Grimison
Michelle Harrison |
Meera Agar
Michelle Butler
Kelly Mok |
|
Publications and Presentations by Advanced Trainees
Advanced Trainees are encouraged to do clinical research and present their findings at local, national and international forums. Below is a list of publications, oral and poster presentations by past and present trainees on work they did while training within SESIAHS. The position of authorship in publications is preserved and the trainee’s name is underlined.
2009
Publication
Matthew Links; Morteza Aghmesheh, Second opinions: Agendas and ego. Acta Oncologica, May 2009 (5)
Lee CK, Hadley A, Desilva K, Smith G, Goldstein D. When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis. World Journal of Surgical Oncology 2009, 7:8.
Oral Presentation
K Webber CRP predicts tolerance of treatment and overall survival with weekly carboplatin and paclitaxel chemotherapy and concurrent irradiation for locally advanced NSCLC- accepted for oral presentation MOGA 2009 and poster presentation for the World Conference on Lung Cancer, San Francisco, Jul 2009
Poster
Morteza Aghmesheh, Matthew Links, Second Opinion: Agendas and Ego, poster presentation for COSA 35th Annual Scientific Meeting, Sydney, Australia.
K.Sjoquist, D.Goldstein Weekly paclitaxel as second line chemotherapy in metastatic gastric or gastro-oesophageal cancer: a single institution retrospective case series and review of the literature. Poster presentation -COSA 2008.
K. Sjoquist, D.Morris, W. Liauw The natural history of papillary type peritoneal type mesothelioma treated with Peritonectomy and Heated IntraPeritoneal Chemotherapy (HIPEC) Abstract accepted for Poster, MOGA Meeting August 2009.
2008
Publication
Harris CA & Goldstein D. Advances in the Treatment Options for Patients with Pancreatic Cancer. Review article: Touch Briefing -Asia Pacific Oncology & Haematology- Volume 1 (Online)
Mok K, Juraskova I, Friedlander M. The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions. The Breast, Vol 17, Issue 5, Pages 436-440, 2008.
Published Abstract
Lee CK, Choo E, Kitching P, Lewis C. Clinico-pathologic characteristics and survival outcomes in triple negative breast cancer – a retrospective analysis of a single centre experience. Asia Pacific Journal Clinical Oncology 2008;4 (Suppl 1):A7-8 for oral presentation at MOGA ASM 2008
Lee CK, Choo E, Kitching P, Lewis C. Breast cancer with triple-negative phenotype has poor pathological characteristics and inferior survival outcomes. Asia Pacific Journal Clinical Oncology 2008;4 (Suppl 2):A29- A83
Poster
A. M. Hadley, W. Lynch, P. Nash, P. Aslan, D. Malouf, P. Galettis, S. Begbie, N. Awad, L. O'Malley, E. Hovey, P. De Souza. Phase II trial of intravesical gemcitabine in patients with urothelial carcinoma of the bladder. ASCO Genitourinary Cancers Symposium, 2008
Bastick, P. Faedo, M. van Gool, K. Pearson, S. Haas, M. and Ward, R. "Rationing High Cost Cancer Medicines: Building the evidence base to support local decision makers" MOGA ASM August 2008
Harris CA, Liauw W, King J, Morris DL, Quinn R, Glenn D, Does selective internal radiotherapy cause late radiation hepatic fibrosis and portal hypertension? MOGA ASM August 2008
2007
Publication
Grimison P, Galettis P, Manners S, Jelinek M, Metharom E, DeSouza P, Liauw W, Links M: A randomised crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation. Journal of Clinical Oncology 2007;25(36): 5704-5709 (PMID 18089865).
C. K. Lee, J. Lynch. Hand–foot syndrome in breast cancer patients receiving adjuvant chemotherapy, Internal Medicine Journal 2007, 37(4): 281–282 [IF 1.402]
Easton, DF. Pooley, KA. … Aghmesheh, M… Cox, DR. Ponder, BAJ. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007; 447 (7148): 1087-1093.
Published Oral Abstract
Mok K, Juraskova I, S Jarvis, Mireskandari S, Meiser B, Peate M & Friedlander M. OVER (Olive oil, Vaginal Exercises and Replens) come: Results of an intervention study to improve sexual function in women with breast cancer. Asia-Pacific Journal of Clinical Oncology 2007; 3 (Suppl 2):A49. - (for oral presentation by Kelly Mok in COSA ASM, November 2007)
CK Lee, P Bastick, W Liauw. Women from non-English speaking backgrounds living in NSW present with later stage breast cancer: a population study. Asia-Pacific Journal of Clinical Oncology 2007; 3 (Suppl 2):A44 – (for oral presentation by Chee Lee in COSA ASM, November 2007 and presented as abstract 2007 ASCO Annual Meeting Abstract No:17043)
Bagia M, Mok K & De Souza P. Chemotherapy in hormone refractory prostate cancer (HRPC): Is there a role for carboplatin and etoposide? Asia-Pacific Journal of Clinical Oncology 2007; 3 (Suppl 2):A64 - (for oral presentation by Mamta Bagia in COSA ASM, November 2007)
Published Poster Abstract
M Chin, M Szwajcer, W Liauw, P de Souza, M Links. Lessons learnt in evaluating the target of drug action in a phase 1 trial of oral albendazole –a benzimidazole carbamate anti-helminthic- in patients with cancer refractory to conventional treatments. Asia Pacific Journal of Clinical Oncology 2007; Vol 3 supplement 2: A79 –( for COSA ASM 2007)
Harris CA, Friedlander M, Carmody J, Kiernan M. Mitoxantrone Use in Multiple Sclerosis. Asia Pacific Journal of Clinical Oncology 2007; Vol 3 supplement 2: A84 – (for COSA ASM 2007)
2006
Publication
Grimison PS, Chin M, Harrison M, Goldstein D. Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer 2006;6(1):117 (PMID 16674812).
Harrison, M. L. and Goldstein D. (2006) Management of metastatic GIST in the post Glivec Era. A practical case based approach. Internal Medical Journal, 6, 367-377
Harrison, M. L., Hoskins, P., du Bois, A., Quinn, M., Rustin, G. J. S., Ledermann, J. A., Baron-Hay, S. and Friedlander M. L. (2006) Small cell of the ovary, hypercalcemic type-Analysis of combined experience and recommendation for management. A GCIG study. Gynecologic Oncology, 100, 233-238
Harrison, M.L., Marx, G. M., Hacker N.F., and Friedlander, M.F. (2005) EAGC Book on chemotherapy. 2nd Ed. What Gynecology Oncologists should know about chemotherapy. Principles and practice of anticancer drug therapy, Chapter 18: Cytotoxic drug treatment of vulva and vaginal cancer. (Ed. Peter Bosze and Maurie Markman)
Morteza Aghmesheh; Zhenhe Suo; Michael Friedlander; Jahn M Nesland; Janne Kaern; Michael Stewart; Kconfab; Anne Dorum; Katherine M Tucker; Michael F Buckley. Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas. Pathology, 2006 Apr; 38: 145-51.
Mok K, & Goldstein D. (2006) Hypersensitivity reactions to oxaliplatin. Can patients be rechallenged? Asia-Pacific Journal of Clinical Oncology 2:175-179.
K Mok, S Mireskandari, I Juraskova, S Jarvis, B Meiser, M Peate & M Friedlander. (2006) OVER (Olive oil, Vaginal Exercises and Replens) come: An intervention study to improve sexual function in women with breast cancer. Psycho-Oncology 15(S2): S778.
Published Oral Abstract
CK Lee, T Dunlop, J Lynch. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy. Internal Medicine Journal 2006; 36 supplement 4: A 148 – (for oral presentation by Chee Lee, MOGA ASM August 2006)
Published Poster Abstract
M Chin, & P de Souza. Cutaneous metastases from prostate cancer. Internal Medicine Journal 2006; 36 supplement 4: A 154 - (for MOGA ASM August 2006)
2005
Publication
Grimison P, Goldstein D, Yeo B. An unusual abdominal mass. Gut 2005;54(4):478, 514 (PMID ID 15753531).
Grimison P, Goldstein D, Schneeweiss J, Murray N. Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms. Internal Medicine Journal 2005;35(2):136-7 (PMID 15705148)
J Kaern, M Aghmesheh, J M Nesland, H E Danielsen, B Sandstad, M Friedlander, C Tropé. Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors? Int J Gynecol Cancer, 2005 Nov;15:1014-22
Morteza Aghmesheh; Lyndal Edwards; Christine L Clarke; Karen Byth; Benita S Katzenellenbogen; Pamela J Russell; Michael Friedlander; Katherine M Tucker; Anna de Fazio. Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecol Oncol, 2005 Apr; 97:16-25
ML Harrison, P Hoskins, A du Bois, M Quinn, G J S Rustin, J A Ledermann, S Baron-Hay, M L Friedlander; Gynecol Oncol. 2005 Nov 27; 16321429 Small cell of the ovary, hypercalcemic type-Analysis of combined experience and recommendation for management. A GCIG study.
Published Oral Abstract
Grimison P, Galettis P, Manners S, Jelinek M, Flynn T, DeSouza P, Liauw W, Goldstein D, Links M. Plasma and intracellularpharmacokinetics of gemcitabine: 100 min versus 30 min infusion. Asia-Pacific Journal of Clinical Oncology, COSA ASM Proceedings 2005;1(s1):A25 – (for oral presentation by Peter Grimison at COSA ASM, November 2005)
Published Poster Abstract
Grimison P, Kaplan J, Hawgood L, DeSouza P. Pattern of PSA responses following docetaxel and carboplatin in hormone refractory prostate carcinoma (HRPC). Asia-Pacific Journal of Clinical Oncology; COSA ASM Proceedings 2005; 1(s1):A39
Oral presentation
P Bastick, C Chan, L Browne, J Lynch, P Graham, W Liauw. "New Australians Breast Cancer Outcomes Project (NABCO)". MOGA ASM 2005
Poster
Harrison, M. L., Andrews, L. and Tucker, K. Outcome for patients with BRCA mutations. kConFab/AOCS, ACCFS Family Cancer Clinic meeting, Couran Cove, Australia 2005 (Abst 13)
Harrison, M. L., Katekova, I., Andrews, L., Mullan, G. and Tucker, K. Referrals for Hereditary Breast and Ovarian Cancer, 10-year experience. kConFab/AOCS, ACCFS Family Cancer Clinic meeting, Couran Cove, Australia 2005 (Abst 14)
Mok K, Goldstein D. Hypersensitivity reactions to oxaliplatin – an audit of our institution’s experience. MOGA ASM, Tasmania, 2005
2004
Publication
Aghmesheh M, Friedlander M, Russell PJ, Edwards L, Yang J-L, kConFab, Nesland JM, Danielson H, Kaern J, Tucker KM. BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian cancer. ASCO, 2004. J Clin Oncol 2004; 22(14): 459S, Suppl.
Morteza Aghmesheh, Jahn M Nesland; Janne Kaern; Anne Dorum; Lyndal Edwards; Karen Byth; Michael Friedlander; Paul Jackson; Katherine M Tucker; Pamela J Russell. No differences in p53 mutation frequencies between BRCA1- associated and sporadic ovarian cancers. Gynecol Oncol, 2004 Dec; 95:430-6.
2003
Publication
Harrison, M. L., Goldstein, D., Jennings, R., and Zalcberg, J. (2003) Edrecelomab as adjuvant therapy in stage III colon cancer. Australian Oncology, 8, 1-2
Poster
Harrison, M. L. and Links, M. Why do patients present after hours to an oncology service? A prospective study. COSA ASM 2003
Morteza Aghmesheh; Lyndal Edwards; Christine L. Clarke; Karen Byth; Benita S. Katzenellenbogen; kConFab; Pamela J. Russell; Michael Friedlander; Katherine M. Tucker; Anna deFazio. Expression of steroid hormone receptors is similar between BRCA1-associated and sporadic ovarian carcinomas. Familial Cancer 2003: Research and Practice, September 4-6, Qld, Australia.
Patricia A. Mote, Yoke-Eng Chiew, Morteza Aghmesheh, Rosemary Balleine, Natalie Gava, Lyndal Edwards, Katherine M. Tucker, Christine L. Clarke and Anna deFazio. Expression of progesterone receptors a and b in ovarian epithelium and serous tumours of the ovary. Familial Cancer 2003: Ovarian Cancer Meeting, September 4-6, Qld, Australia.
Morteza Aghmesheh; Lyndal Edwards; Janne Kaern; Michael Stewart; kConFab; Jahn M. Nesland; Anne Dorum; Michael Friedlander; Michael Buckley and Katherine M. Tucker. Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas. Familial Cancer 2003: Research and Practice, September 4-6, Qld, Australia.
2002
Publication
Harrison, M. L. and Goldstein, D. (2002) Prolonged survival in a patient with an occult primary small-cell lung cancer and a solitary brain metastasis at diagnosis. Internal Medicine Journal, 32, 621-622
Poster
Aghmesheh, M.; Edwards, L.; Clark, C.; Russell, P.J.; KconFab; Friedlander, M.; Tucker,K.; deFazio,A. Steroid Hormone Receptor Expression In Hereditary And Sporadic Ovarian Cancers. 92nd Annual Meeting of American Association for Cancer Research (AACR), April 7-10, Mascot, San Francisco, USA.
Prizes and Awards won by Trainees
Trainee | Year | Award |
Bavanthi Balakrishnar | 2009 | GSK/MOGA Trainee Travel Award |
Charlotte Lemech | 2009 | GSK/MOGA Trainee Travel Award |
Kate Webber | 2009 | GSK/MOGA Trainee Travel Award |
Katrin Sjoquist | 2009
2009
2008 | GSK/MOGA Trainee Travel Award
Best of Grand Rounds/Wiley-Blackwell Award for Clinical Excellence, RACP Physicians' Week
TOW Award, Prince of Wales Hospital, Winner Medicine Division |
Chee Lee | 2008 | Amgen Australia Advanced Trainee ASCO Travel Award |
Alison Hadley | 2008 | ASCO Genitourinary (GU) Cancers Symposium Merit Award |
Morteza Aghemesh | 2007 | MOGA-Roche Australia Travel Award |
Carole Harris | 2007 | TOW award, Prince of Wales Hospital. Best Physician Case History |
Chee Lee | 2006 | MOGA ASM GlaxoSmithKline award for oral presentation |
Lorraine Chantrill | 2006 | MOGA-Ipsen Travel Award |
Kelly Mok | 2006 | NSW Cancer Institute Clinical Fellowship |
Patricia Bastick | 2005 | MOGA ASM GlaxoSmithKline award for oral presentation |
Peter Grimison | 2005
2004 | MOGA/Pfizer Australia Trainee Travel Award
Best Teacher Award (Registrar Category), Prince of Wales Hospital |
Australia and Asia Pacific Clinical Oncology Research Development Workshop (ACORD)
The ACORD workshop is a bi-annual event bringing an international faculty to help junior researchers design and execute clinical trials. Participants are selected through a competitive application process. For more information see http://www.acordworkshop.org.au
Year | Trainees |
2008 | Carole Harris
Mamta Bagia
Morteza Aghemesh |
2006 | Melvin Chin
Peter Grimison
Lorraine Chantrill |
2004 | Meera Agar
Kelly Mok |
Where are they now?
Trainee | Year Completed / Year of Advanced Training | Current Job | Other Career Highlights |
| Meera Agar | 2004 | Director of Palliative Care, Braeside Hospital | Current PhD student, Department of palliative and supportive services, Flinders University |
| Morteza Aghemesh | 2008 | Staff Specialist Medical Oncologist Wollongong Hospital. Senior Clinical Lecturer, Graduate School of Medicine, University of Wollongong | Completed a PhD in cancer genetics and Graduate Diploma in molecular genetics at the University of NSW, prior to clinical training. |
| Mamta Bagia | 2008 | Clinical Research Fellow, NHMRC Clinical Trials Centre, University of Sydney | |
| Bavanthi Balakrishnar | 1st year | Registrar, St George Hospital | |
| Patricia Bastick | 2008 | Cancer Institute NSW Post-Graduate Fellow, Prince of Wales Hospital | |
| Michelle Butler | 2008 | Palliative Care, Sacred Heart Hospice, Sydney | |
| Lorraine Chantrill | 2007 | Staff Specialist, Macarthur Cancer Care Centre, Campbelltown Hospital | |
| Melvin Chin | 2007 | Clinical Fellow, Prince of Wales and St Vincent's Hospitals | |
| Arthur Clements | 3rd year | Registrar, St George Hospital | |
| Rasha Cosman | 1st year | Registrar, St George Hospital | |
| Tracey Dunlop | 2nd year (deferred) | On maternity leave | |
| Peter Grimison | 2006 | Staff Specialist in Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred and Dubbo Base Hospitals | Previous Research Fellow in Medical Oncology, University of Sydney. Submitted PhD thesis, University of Sydney |
| Alison Hadley | 2007 | Staff Specialist in Medical Oncology, Cancer
Care Services, Royal Brisbane and Women’s Hospital, Herston | |
| Carole Harris | 3rd year | PhD student, UNSW Cancer Research Centre | |
| Michelle Harrison | 2004 | Staff Specialist, Royal Prince Alfred and Liverpool Hospitals | Consultant Medical Oncologist, Royal Marsden |
| Jason Kaplan | Final year cardiology advanced trainee | Cardiology Fellow, Royal Prince Alfred Hospital | |
| Alan Landau | 1st year | Registrar, Prince of Wales & Wollongong Hospitals | |
| Chee Lee | 2008 | PhD student, NHMRC Clinical Trials Centre, University of Sydney |  Medical Oncology Research Fellow (P/T), Prince of Wales Hospital
Staff Specialist in Medical Oncology (P/T), St George Hospital |
| Charlotte Lemech | 1st year | Registrar, Prince of Wales & Wollongong Hospitals | |
| Kelly Mok | 2006 | Lecturer, University of NSW | Cancer Institute NSW Clinical Fellow 2006
Current PhD student, University of NSW |
| Katrin Sjoquist | 2nd year | Registrar, St George Hospital | |
| Kate Webber | 2nd year | Registrar, Prince of Wales Hospital | |
|
Contact
Dr Melvin Chin
Clinical Fellow in Medical Oncology
Medical Professorial Unit
Prince of Wales Clinical School
Level 1, South Wing, Edmund Blacket Building
POW Hospital, Avoca Street
RANDWICK NSW 2031
T +61 (2) 9382 8867
F +61 (2) 9382 8885
E Melvin.chin@unsw.edu.au
|
|